Top stories

India can use Biotech Kovasin as a backup, says AIMS director

On Sunday, India’s Drug Controller General (DCGI) approved the urgent use of two vaccines against the coronavirus. A vaccination campaign against the corona virus will be launched in the country soon. Randeep Guleria, director of the All India Institute of Medical Sciences (AIIMS), said after clearing two vaccines at the same time, it was a good day for the country and a good way to start the new year.

He added that one of the two approved vaccines, a native covacin, could be used as a backup. He said that two vaccines are made in India. Which is expensive and readily available. Guleria said we should start vaccinating in a very short time. He said vaccines go through various stages to ensure they are safe. The Ames director further said that all the information is seriously examined and tested by experts after which the vaccine is approved.

Read more – Vaccine App Launched? Learn everything about Co-Win

Guleria said India biotech vaccines could be used as a backup. We need to be vaccinated when there is a sudden increase in corona in case of emergency, but India Biotech vaccine can be used. He further added that India Biotech vaccine can be used when we are not sure how effective the Serum Institute vaccine is.

India’s drug regulator on Sunday approved limited emergency use in Covishield, the home-grown vaccine Serum Institute of India and the Oxford Covid-19 vaccine Covishield and India Biotech. The Covid-19 of the Central Drugs Standards Control Organization (CDSCO) has been approved by the Drug Controller General of India (DCGI) on the recommendation of the Subject Expert Committee (SEC).

DCGI Dr VG Somani while talking to media said that CDSCO has decided to accept the recommendation of expert committee after adequate study and has approved the limited use of Messrs. Serum and Messrs. Bharat Biotech vaccines in case of emergency. This is being done.


Show More

Related Articles

Leave a Reply

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker